Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Evaluation of Six Commercial and Non-Commercial Colistin Resistance Diagnostics

View ORCID ProfileTumisho Mmatumelo Seipei Leshaba, View ORCID ProfileMasego Mmatli, View ORCID ProfileLebogang Skosana, View ORCID ProfileNontombi Marylucy Mbelle, View ORCID ProfileJohn Osei Sekyere
doi: https://doi.org/10.1101/2024.03.21.24304472
Tumisho Mmatumelo Seipei Leshaba
aDepartment of Medical Microbiology, School of Medicine, University of Pretoria, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tumisho Mmatumelo Seipei Leshaba
Masego Mmatli
aDepartment of Medical Microbiology, School of Medicine, University of Pretoria, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Masego Mmatli
Lebogang Skosana
aDepartment of Medical Microbiology, School of Medicine, University of Pretoria, South Africa
bDepartment of Medical Microbiology, Tshwane Academic Division, National Health Laboratory Service, Pretoria, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lebogang Skosana
Nontombi Marylucy Mbelle
aDepartment of Medical Microbiology, School of Medicine, University of Pretoria, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nontombi Marylucy Mbelle
John Osei Sekyere
aDepartment of Medical Microbiology, School of Medicine, University of Pretoria, South Africa
cDepartment of Dermatology, School of Medicine, University of Pretoria, South Africa
dInstitute of Biomarker Research, Medical Diagnostic Laboratories, Genesis Biotechnology Group, Hamilton, NJ, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John Osei Sekyere
  • For correspondence: j.oseisekyere{at}up.ac.za jod14139{at}gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Data Availability

All data produced in the present work are contained in the manuscript

Back to top
PreviousNext
Posted March 22, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of Six Commercial and Non-Commercial Colistin Resistance Diagnostics
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evaluation of Six Commercial and Non-Commercial Colistin Resistance Diagnostics
Tumisho Mmatumelo Seipei Leshaba, Masego Mmatli, Lebogang Skosana, Nontombi Marylucy Mbelle, John Osei Sekyere
medRxiv 2024.03.21.24304472; doi: https://doi.org/10.1101/2024.03.21.24304472
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Evaluation of Six Commercial and Non-Commercial Colistin Resistance Diagnostics
Tumisho Mmatumelo Seipei Leshaba, Masego Mmatli, Lebogang Skosana, Nontombi Marylucy Mbelle, John Osei Sekyere
medRxiv 2024.03.21.24304472; doi: https://doi.org/10.1101/2024.03.21.24304472

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pathology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)